The study you linked does not prove what you think it does. Check out the inclusion criteria: > Inclusion criteria were a first COVID-19 diagnosis during the A

The study you linked does not prove what you think it does. Check out the inclusion criteria: > Inclusion criteria were a first COVID-19 diagnosis during the April 1, 2020 - March 31, 2021 time period, with an outpatient visit 1 month to 2 years before, and another 6 months to 2 years before that To actually compare fairly against vaccination, you need to compare the infection myocarditis rate, not the case myocarditis rate. (Technically you should really compare infection myocarditis rate * chance of actually getting infected w/ SARS-2 [while very slightly adjusting for time decay], but let's ignore that especially since the chance of getting COVID over a 2-3 year window is quite high) So the study you linked will give an unfairly high estimate of the rate of myocarditis. This is the same principle as the fact that looking at hospitalized COVID-19 patients will show much worse effects than looking at rates of bad effects for all PCR+ individuals, and even moreso if extrapolating from serology.